Kim, J. H., Cosman, R., Steer, C., Lee, J., Kim, J. H., Rha, S. Y., Im, S., Park, Y. H., Jung, K. H., Zhang, S. Y. (2026). Phase Ia study of VRN101099, a brain-penetrant, highly selective covalent HER2 inhibitor, in HER2-positive or HER2-mutant advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1048